ClinicalTrials.Veeva

Menu
D

DBC Research Corp | Tamarac, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ontamalimab
PUL-042
Methotrexate
Pomotrelvir
HZN-825
PBI-0451
Testosterone
SHP647

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

HZNP-HZN-825-303 (HARBOR) comprises of 2 parts. Part 1 (Core Phase) is a randomized, double-blind, placebo-controlled, repeat-dose, multicenter trial...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: HZN-825
Drug: Placebo

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI-0451(Pomotrelvir)...

Active, not recruiting
COVID-19
Drug: Placebo
Drug: PBI-0451 (Pomotrelvir)

Trial sponsors

Shire logo
P
AbbVie logo
Amgen logo
Janssen (J&J Innovative Medicine) logo
Mass General Brigham logo
P
ZOLL Medical logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems